{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T00:35:12Z","timestamp":1785285312721,"version":"3.55.0"},"reference-count":31,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2016,10,31]],"date-time":"2016-10-31T00:00:00Z","timestamp":1477872000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Brain and Behavior"],"published-print":{"date-parts":[[2017,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Objective<\/jats:title><jats:p>Serum uric acid (<jats:styled-content style=\"fixed-case\">UA<\/jats:styled-content>) levels are reported to be decreased in patients with Parkinson's disease (<jats:styled-content style=\"fixed-case\">PD<\/jats:styled-content>) and multiple system atrophy (<jats:styled-content style=\"fixed-case\">MSA<\/jats:styled-content>). However, clinical correlates of serum <jats:styled-content style=\"fixed-case\">UA<\/jats:styled-content> levels are still unclear in <jats:styled-content style=\"fixed-case\">PD<\/jats:styled-content>\u2010related disorders. We conducted a cross\u2010sectional study to evaluate the associations between serum <jats:styled-content style=\"fixed-case\">UA<\/jats:styled-content> levels and disease duration, disease severity, and motor function among <jats:styled-content style=\"fixed-case\">PD<\/jats:styled-content>,<jats:styled-content style=\"fixed-case\"> MSA<\/jats:styled-content>, and progressive supranuclear palsy (<jats:styled-content style=\"fixed-case\">PSP<\/jats:styled-content>) patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A total of 100 patients with <jats:styled-content style=\"fixed-case\">PD<\/jats:styled-content>, 42 patients with <jats:styled-content style=\"fixed-case\">MSA<\/jats:styled-content>, 30 patients with <jats:styled-content style=\"fixed-case\">PSP<\/jats:styled-content>, and 100 controls were included in this study. Serum <jats:styled-content style=\"fixed-case\">UA<\/jats:styled-content> levels were determined, and associations among serum <jats:styled-content style=\"fixed-case\">UA<\/jats:styled-content> levels and disease duration, disease severity, and motor function in <jats:styled-content style=\"fixed-case\">PD<\/jats:styled-content>,<jats:styled-content style=\"fixed-case\"> PSP<\/jats:styled-content>, and <jats:styled-content style=\"fixed-case\">MSA<\/jats:styled-content> patients were evaluated.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Serum <jats:styled-content style=\"fixed-case\">UA<\/jats:styled-content> levels were significantly lower in male <jats:styled-content style=\"fixed-case\">PD<\/jats:styled-content>,<jats:styled-content style=\"fixed-case\"> MSA<\/jats:styled-content>, and <jats:styled-content style=\"fixed-case\">PSP<\/jats:styled-content> patients compared with the controls, but not in female patients. Serum <jats:styled-content style=\"fixed-case\">UA<\/jats:styled-content> levels were negatively correlated with disease duration and severity in <jats:styled-content style=\"fixed-case\">MSA<\/jats:styled-content> and <jats:styled-content style=\"fixed-case\">PSP<\/jats:styled-content> patients, but no correlations were observed in <jats:styled-content style=\"fixed-case\">PD<\/jats:styled-content> patients. The serum <jats:styled-content style=\"fixed-case\">UA<\/jats:styled-content> levels were significantly decreased in the tauopathy group (<jats:styled-content style=\"fixed-case\">PSP<\/jats:styled-content> patients) compared with the synucleinopathy group (<jats:styled-content style=\"fixed-case\">PD<\/jats:styled-content> and <jats:styled-content style=\"fixed-case\">MSA<\/jats:styled-content> patients) after adjusting for age, gender, and body mass index.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>We found decreased serum <jats:styled-content style=\"fixed-case\">UA<\/jats:styled-content> levels in male patients with <jats:styled-content style=\"fixed-case\">PD<\/jats:styled-content>\u2010related disorders (<jats:styled-content style=\"fixed-case\">PD<\/jats:styled-content>,<jats:styled-content style=\"fixed-case\"> MSA<\/jats:styled-content>, and <jats:styled-content style=\"fixed-case\">PSP<\/jats:styled-content>) compared with male controls, and significant correlations between serum <jats:styled-content style=\"fixed-case\">UA<\/jats:styled-content> levels and disease severity in <jats:styled-content style=\"fixed-case\">MSA<\/jats:styled-content> and <jats:styled-content style=\"fixed-case\">PSP<\/jats:styled-content> patients.<\/jats:p><\/jats:sec>","DOI":"10.1002\/brb3.598","type":"journal-article","created":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T03:33:01Z","timestamp":1477971181000},"source":"Crossref","is-referenced-by-count":35,"title":["Serum uric acid levels in Parkinson's disease and related disorders"],"prefix":"10.1002","volume":"7","author":[{"given":"Hideki","family":"Sakuta","sequence":"first","affiliation":[{"name":"Department of Neurology Dokkyo Medical University  Mibu Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keisuke","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Department of Neurology Dokkyo Medical University  Mibu Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoyuki","family":"Miyamoto","sequence":"additional","affiliation":[{"name":"Department of Neurology Dokkyo Medical University Koshigaya Hospital  Koshigaya Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Miyamoto","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine for Nursing Dokkyo Medical University School of Nursing  Mibu Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayaka","family":"Numao","sequence":"additional","affiliation":[{"name":"Department of Neurology Dokkyo Medical University  Mibu Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Fujita","sequence":"additional","affiliation":[{"name":"Department of Neurology Dokkyo Medical University  Mibu Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuji","family":"Watanabe","sequence":"additional","affiliation":[{"name":"Department of Neurology Dokkyo Medical University  Mibu Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Hirata","sequence":"additional","affiliation":[{"name":"Department of Neurology Dokkyo Medical University  Mibu Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2016,10,31]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clineuro.2009.06.012"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.21502"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2007.11.001"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2011.01.013"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/0026-0495(86)90152-6"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-013-7006-z"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwp033"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/ane.12012"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1002\/1531-8257(200003)15:2<276::AID-MDS1010>3.0.CO;2-Q"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.1989.tb07264.x"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12031-010-9409-y"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.10486"},{"key":"e_1_2_7_14_1","doi-asserted-by":"crossref","first-page":"499","DOI":"10.3233\/JPD-140353","article-title":"Serum uric acid concentration is linked to wearing\u2010off fluctuation in Japanese Parkinson's disease patients","volume":"4","author":"Fukae J.","year":"2014","journal-title":"Journal of Parkinson's Disease"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1124\/pr.109.002071"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000324625.00404.15"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.2174\/138161205774913255"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.17.5.427"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.55.3.181"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.47.6_Suppl_3.161S"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.20663"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.47.1.1"},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.1002\/acn3.167"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/463483"},{"key":"e_1_2_7_25_1","doi-asserted-by":"publisher","DOI":"10.1111\/ane.12295"},{"key":"e_1_2_7_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2014.03.016"},{"key":"e_1_2_7_27_1","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwq195"},{"key":"e_1_2_7_28_1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.26466"},{"key":"e_1_2_7_29_1","doi-asserted-by":"publisher","DOI":"10.1159\/000342483"},{"key":"e_1_2_7_30_1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.22139"},{"key":"e_1_2_7_31_1","first-page":"583","article-title":"Association of serum uric acid levels with the progression of Parkinson's disease in Chinese patients","volume":"125","author":"Sun C. C.","year":"2012","journal-title":"Chinese Medical Journal"},{"key":"e_1_2_7_32_1","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwm127"}],"container-title":["Brain and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fbrb3.598","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fbrb3.598","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/brb3.598","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,6]],"date-time":"2023-10-06T16:17:26Z","timestamp":1696609046000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/brb3.598"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,31]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["10.1002\/brb3.598"],"URL":"https:\/\/doi.org\/10.1002\/brb3.598","archive":["Portico"],"relation":{},"ISSN":["2162-3279","2162-3279"],"issn-type":[{"value":"2162-3279","type":"print"},{"value":"2162-3279","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,31]]},"article-number":"e00598"}}